D. Gareth Evans

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Genome-wide association study identifies novel breast cancer susceptibility loci

Prophylactic Oophorectomy in Carriers of<i>BRCA1</i>or<i>BRCA2</i>Mutations

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)

Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service